Hepatitis C virus

Preview

Research on the hepatitis C virus (HCV) is currently very active, and a continuous stream of advances is coming forth. In this article, the authors present some recent developments in epidemiology and diagnosis, examine the relationship of HCV infection to other medical disorders, and discuss the effectiveness of current drug therapy.

Additional information

Notes on contributors

Franklin Dana

Franklin Dana, MD Paul R. Becherer, MD Bruce R. Bacon, MD Dr Dana is a resident, department of radiology, University of Florida Health Sciences Center, Jacksonville. Dr Becherer is assistant professor of internal medicine, division of infectious diseases and immunology, and Dr Bacon is professor of internal medicine and director, division of gastroenterology and hepatology, St Louis University School of Medicine.

Paul R. Becherer

Franklin Dana, MD Paul R. Becherer, MD Bruce R. Bacon, MD Dr Dana is a resident, department of radiology, University of Florida Health Sciences Center, Jacksonville. Dr Becherer is assistant professor of internal medicine, division of infectious diseases and immunology, and Dr Bacon is professor of internal medicine and director, division of gastroenterology and hepatology, St Louis University School of Medicine.

Bruce R. Bacon

Franklin Dana, MD Paul R. Becherer, MD Bruce R. Bacon, MD Dr Dana is a resident, department of radiology, University of Florida Health Sciences Center, Jacksonville. Dr Becherer is assistant professor of internal medicine, division of infectious diseases and immunology, and Dr Bacon is professor of internal medicine and director, division of gastroenterology and hepatology, St Louis University School of Medicine.